A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in European Patients in the Course of Routine Clinical Care (I5Q-MC-B002) First published 17/01/2019 Last updated 28/10/2024 EU PAS number:EUPAS27594 Study Ongoing